Literature DB >> 20817289

The relationship between external beam radiotherapy dose and chronic urinary dysfunction--a methodological critique.

Tara Rosewall1, Charles Catton, Geoffrey Currie, Andrew Bayley, Peter Chung, Janelle Wheat, Michael Milosevic.   

Abstract

PURPOSE: To perform a methodological critique of the literature evaluating the relationship between external beam radiotherapy dose/volume parameters and chronic urinary dysfunction to determine why consistent associations between dose and dysfunction have not been found. METHODS AND MATERIALS: The radiotherapy literature was reviewed using various electronic medical search engines with appropriate keywords and MeSH headings. Inclusion criteria comprised of; English language articles, published between 1999 and June 2009, incorporating megavoltage external beam photons in standard-sized daily fraction. A methodological critique was then performed, evaluating the factors affected in the quantification of radiotherapy dose and chronic urinary dysfunction.
RESULTS: Nine of 22 eligible studies successfully identified a clinically and statistically significant relationship between dose and dysfunction. Accurate estimations of external beam radiotherapy dose were compromised by the frequent use of dosimetric variables which are poor surrogates for the dose received by the lower urinary tract tissue and do not incorporate the effect of daily variations in isocentre and bladder position. The precise categorization of chronic urinary dysfunction was obscured by reliance on subjective and aggregated toxicity metrics which vary over time.
CONCLUSIONS: A high-level evidence-base for the relationship between external beam radiotherapy dose and chronic urinary dysfunction does not currently exist. The quantification of the actual external beam dose delivered to the functionally important tissues using dose accumulation strategies and the use of objective measures of individual manifestations of urinary dysfunction will assist in the identification of robust relationships between dose and urinary dysfunction for application in widespread clinical practice. Crown
Copyright © 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20817289     DOI: 10.1016/j.radonc.2010.08.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

1.  Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer.

Authors:  Pirus Ghadjar; Michael J Zelefsky; Daniel E Spratt; Per Munck af Rosenschöld; Jung Hun Oh; Margie Hunt; Marisa Kollmeier; Laura Happersett; Ellen Yorke; Joseph O Deasy; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

2.  Peritoneal bladder fistula following radiotherapy for cervical cancer: A case report.

Authors:  Fan Shi; Tao Wang; Jiquan Wang; Beina Hui; Yanlan Chai; Juan Wang; Zi Liu
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

3.  Urinary bladder dose-response relationships for patient-reported genitourinary morbidity domains following prostate cancer radiotherapy.

Authors:  Maria Thor; Caroline Olsson; Jung Hun Oh; Stine Elleberg Petersen; David Alsadius; Lise Bentzen; Niclas Pettersson; Ludvig Paul Muren; Morten Høyer; Gunnar Steineck; Joseph O Deasy
Journal:  Radiother Oncol       Date:  2016-02-12       Impact factor: 6.280

4.  Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer.

Authors:  A Zapatero; M Roch; D Büchser; P Castro; L Fernández-Banda; G Pozo; O Liñán; C Martin de Vidales; A Cruz-Conde; F García-Vicente
Journal:  Clin Transl Oncol       Date:  2017-04-03       Impact factor: 3.405

5.  Dose-response of acute urinary toxicity of long-course preoperative chemoradiotherapy for rectal cancer.

Authors:  Ane L Appelt; Søren M Bentzen; Anders Jakobsen; Ivan R Vogelius
Journal:  Acta Oncol       Date:  2014-06-30       Impact factor: 4.089

6.  The Therapeutic Effect of Adipose-Derived Mesenchymal Stem Cells for Radiation-Induced Bladder Injury.

Authors:  Xuefeng Qiu; Shiwei Zhang; Xiaozhi Zhao; Kai Fu; Hongqian Guo
Journal:  Stem Cells Int       Date:  2016-03-08       Impact factor: 5.443

7.  Coronavirus disease 2019 (COVID-19) in patients before, during, or after lung irradiation, and serum SP-A and SP-D levels.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Masahiro Okada
Journal:  Thorac Cancer       Date:  2022-09-30       Impact factor: 3.223

8.  Incidence of genitourinary complications following radiation therapy for localised prostate cancer.

Authors:  Rowan V David; Arman A Kahokehr; Jason Lee; David I Watson; John Leung; Michael E O'Callaghan
Journal:  World J Urol       Date:  2022-08-11       Impact factor: 3.661

9.  Linking CHHiP prostate cancer RCT with GP records: A study proposal to investigate the effect of co-morbidities and medications on long-term symptoms and radiotherapy-related toxicity.

Authors:  Agnieszka Lemanska; Rachel C Byford; Ana Correa; Clare Cruickshank; David P Dearnaley; Clare Griffin; Emma Hall; Simon de Lusignan; Sara Faithfull
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2017-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.